US Stock MarketDetailed Quotes

DNA Ginkgo Bioworks

Watchlist

0.914
-0.037-3.84%

Close Apr 16 16:00 ET

0.920
+0.007+0.71%

Post 17:59 ET

1.97BMarket Cap-1985P/E (TTM)

Ginkgo Bioworks Stock Forum

BEAN8444

Apr 2 23:21

BAN

$Ginkgo Bioworks(DNA.US)$DEA Agrees To Hold Hearing On Proposed Ban Of Two Psychedelics Amid Pushback From Researchers

Newbie_Mooymooy

Mar 21 18:14

Potential next big thing

$Ginkgo Bioworks(DNA.US)$ This stock has the potential to be the next big thing. The glory has yet to come but it is showing signs

Moomoo AI

Mar 11 20:59

The increase in insider holdings at Ginkgo Bioworks Holdings is seen as a positive sign, indicating that insiders are optimistic about the company's prospects. The high level of insider ownership suggests that management's incentives are well aligned with other shareholders.

Bullish Ginkgo Bioworks Holdings Insiders Loaded Up On US$960.0k Of Stock

101674396

Mar 6 00:45

$Ginkgo Bioworks(DNA.US)$ .. will be drop to below $1

Tommie Mcilwain

Feb 28 08:54

$Ginkgo Bioworks(DNA.US)$ does kathy woods still own this too

BEAN8444

Jan 31 01:59

SELL...

$Ginkgo Bioworks(DNA.US)$Goldman Sachs Maintains Sell on Ginkgo Bioworks Holdings, Lowers Price Target to $1.1 - moomoo

Kevin Travers

Jan 22 23:51

ColumnsBiotTech Rises with the Index Tide

After two major indexes reached all-time highs, pharmaceutical stocks for companies in drug trials were caught up in the energy and rocketed forward. The largest gainers were $Spyre Therapeutics(SYRE.US)$, up 26% Monday morning, and $Gyre Therapeutics(GYRE.US)$ +10%.
Spyre felt the positive pressure from fresh buy ratings by analysts like Stifel. $Ginkgo Bioworks(DNA.US)$ also roase 9%, despite a new sell rating from Goldman Sachs.
But monday morning was not al...